Collegium Pharmaceutical, Inc. (COLL) Stock Overview
Explore Collegium Pharmaceutical, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Collegium Pharmaceutical, Inc. (COLL)
Key Financials
Key Financials
Market Cap
1.2B
P/E Ratio
15.00
EPS (TTM)
$7.73
ROE
0.27%
COLL Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Collegium Pharmaceutical, Inc. (COLL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 50.45, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $45.48.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.00 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.